Cargando…
A micro-elimination approach to addressing hepatitis C in Turkey
BACKGROUND: In 2016, WHO passed the Global Health Sector Strategy on Viral Hepatitis (GHSS), calling for its elimination by 2030. Two years later, Turkey approved a strategy to reach the WHO targets. This study reports new national prevalence data, breaks it down by subpopulation, and models scenari...
Autores principales: | Idilman, Ramazan, Razavi, Homie, Robbins-Scott, Sarah, Akarca, Ulus Salih, Örmeci, Necati, Kaymakoglu, Sabahattin, Aygen, Bilgehan, Tozun, Nurdan, Güner, Rahmet, Bodur, Hurrem, Lazarus, Jeffrey V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7093960/ https://www.ncbi.nlm.nih.gov/pubmed/32209103 http://dx.doi.org/10.1186/s12913-020-5019-8 |
Ejemplares similares
-
1144 Healthcare Acquired Crimean Congo Hemorrhagic Fever in Turkey 2002-2012 - Low Risk of Transmission in Routine Diagnostic Laboratory Practice
por: Leblebicioglu, Hakan, et al.
Publicado: (2014) -
1150 The Disease Burden of Chronic Hepatitis C in Turkey
por: Idilman, Ramazan
Publicado: (2014) -
Subclinical Infections with Crimean-Congo Hemorrhagic Fever Virus, Turkey
por: Bodur, Hürrem, et al.
Publicado: (2012) -
Helicobacter pylori treatment in Turkey: Current status and rational treatment options
por: Kaplan, Mustafa, et al.
Publicado: (2019) -
Risk factors associated with progression to intestinal complications of Crohn disease
por: Kayar, Yusuf, et al.
Publicado: (2019)